Angiogenesis

During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
B1408 CNX-774Summary: BTK inhibitor, orally active, irreversible and selective -
A8790 Cyclo (-RGDfC) -
B7741 BIO 51921 CitationSummary: α4β1 inhibitor -
B7412 RGDS peptideSummary: Integrin binding sequence that inhibits integrin receptor function -
B6664 GR 144053 trihydrochlorideSummary: platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist -
B6003 SB273005Summary: αvβ3 antagonist -
B5770 Leukadherin 1Summary: CD11b/CD18 activator -
B5699 P11Summary: antagonist of the integrin αvβ3-vitronectin interaction -
B5675 ObtustatinSummary: integrin α1β1 inhibitor -
A8677 SLIGKV-NH2Summary: PAR2 agonist
